Team:Braunschweig/Notebook

From 2013.igem.org

(Difference between revisions)
Line 669: Line 669:
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
<b>Investigators: Laura, Kerstin</b><br>
<b>Investigators: Laura, Kerstin</b><br>
-
 
The eforRed expression cassette in <i>E.Coli</i> TOP10F’ was miniprepped and glycerol stocks of this strain were made.<br>
The eforRed expression cassette in <i>E.Coli</i> TOP10F’ was miniprepped and glycerol stocks of this strain were made.<br>
Line 709: Line 708:
     <h2><a href="#Week18">Week 18: September 15 - September 21, 2013</a></h2>
     <h2><a href="#Week18">Week 18: September 15 - September 21, 2013</a></h2>
     <p><p style=" margin-left:5px; margin-right:5px;">
     <p><p style=" margin-left:5px; margin-right:5px;">
-
Week 18</p>
+
This week we were happy to find a workaround for a big troublemaker: the background expression of β-lactamase in non-induced state. We determined the critical concentration of β-lactamase inhibitor clavulanic acid to be around 1 µg/ml. Furthermore, we directly applied it to experiments which previously were problematic because of the resistance to ampicillin under non-induced conditions.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, September 16, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Jan</b><br>
 +
This week started with a quite important experiment: Since we experienced background expression of β-lactamase, our transformed bacteria were relatively resistant to Ampicillin, although cultivated under non-inducing conditions. In this experiment, we added clavulanic acid at different concentrations as a β-lactamase inhibitor to liquid cultures. A concentration of 0.1 µg/ml was enough to remove background expression of β-lactamase, leading to no observable bacterial growth in ampicillin-containing media.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, September 18, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Jan</b><br>
 +
On Wednesday, we repeated the experiment we did on Monday with a different scale of concentration steps to more precisely determine the best concentration of clavulanic acid for future experiments. Unfortunately, all samples showed growth so no further distinction could be made.<br>
 +
Hence, we went ahead with the 1 µg/ml of clavulanic acid we determined on Monday to remove background expression of β-lactamase. We applied this information to ascertain growth behavior of JM109 bacteria transformed with our final blue construct (K1073034). Therefore, we cultivated this strain in 2x YT media with ampicillin and clavulanic acid. Out of four cultures, only two contained the inducer necessary for successful induction of ampicillin resistance.</p>
 +
 
 +
<p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p>
 +
 
 +
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, September 19, 2013</p>
 +
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px">
 +
<b>Investigators: Jan</b><br>
 +
Liquid cultures of 2x YT media with ampicillin and 1 µg/ml clavulanic acid were inoculated at different ratios (based on OD<sub>520</sub>) of JM109 with the final blue construct (K1073034) and Top10 with the final red construct (K1073035). Each culture was also performed with chloramphenicol instead of ampicillin as unregulated control.</p>
   </div>
   </div>

Revision as of 16:57, 3 October 2013

Labjournal

linie rot 8pix hoch

This is the documentation of our lab work. An overview on how we approached this project can be found under Approach. For detailed protocols of certain procedures please refer to Protocols. Attributions are given for each day, however please check our Attributions section for efforts beyond the lab work.

Our sponsors

linie rot 8pix hoch